Cargando…

1522. Safety and Efficacy of CR6261 in an Influenza A H1N1 Healthy Human Challenge Model

BACKGROUND: Influenza virus infections cause significant morbidity and mortality during yearly seasonal epidemics and during sporadic pandemics. It is imperative to identify new targets for vaccines and therapeutics. One such target is the relatively conserved stalk region of the influenza A hemaggl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Alison, Czajkowski, Lindsay, Rosas, Luz Angela, Cervantes-Medina, Adriana, Xiao, Yongli, Gouzoulis, Monica, Lumbard, Keith, Hunsberger, Sally, Reed, Susan, Athota, Rani, Baus, Holly, Lwin, Amy, Sadoff, Jerald, Taubenberger, Jeffery, Memoli, Matthew J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778303/ http://dx.doi.org/10.1093/ofid/ofaa439.1703

Ejemplares similares

2750. Sequential Influenza A H1N1 and Influenza A H3N2 Challenge Infections in Healthy Volunteers
por: Han, Alison, et al.
Publicado: (2019)

723. Validation of a Wild-Type Influenza A/Texas-Like H3N2 Human Challenge Model with Comparison to the Validated A(H1N1)pdm09 Model
por: Han, Alison, et al.
Publicado: (2018)

Evaluation of Preexisting Anti-Hemagglutinin Stalk Antibody as a Correlate of Protection in a Healthy Volunteer Challenge with Influenza A/H1N1pdm Virus
por: Park, Jae-Keun, et al.
Publicado: (2018)

The Molecular Mechanism of Action of the CR6261-Azichromycin Combination Found through Computational Analysis
por: Cui, Wei, et al.
Publicado: (2012)

Evaluation of Antihemagglutinin and Antineuraminidase Antibodies as Correlates of Protection in an Influenza A/H1N1 Virus Healthy Human Challenge Model
por: Memoli, Matthew J., et al.
Publicado: (2016)

The Natural History of Influenza Infection in the Severely Immunocompromised vs Nonimmunocompromised Hosts
por: Memoli, Matthew J., et al.
Publicado: (2014)

Visceral Leishmaniasis during Italian Renaissance, 1522–1562
por: Nerlich, Andreas G., et al.
Publicado: (2012)

1522. Predictors of Weight Gain in People Living with HIV
por: Pedersen, Karen B H, et al.
Publicado: (2023)

Efficacy of FLU-v, a broad-spectrum influenza vaccine, in a randomized phase IIb human influenza challenge study
por: Pleguezuelos, Olga, et al.
Publicado: (2020)

1524. Sex Differences in Influenza: The Challenge Study Experience
por: Giurgea, Luca, et al.
Publicado: (2020)

Laparoscopic Treatment of 1522 Adnexal Masses: An 8-Year Experience
por: Grammatikakis, I., et al.
Publicado: (2015)

Génesis histórica de Chiapas, 1522-1532 : el conflicto entre Portocarrero y Mazariegos /
por: Lenkersdorf, Gudrun
Publicado: (1993)

The effect of calcium and magnesium on activity, immunogenicity, and efficacy of a recombinant N1/N2 neuraminidase vaccine
por: Giurgea, Luca T., et al.
Publicado: (2021)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

Dynamics of SARS-CoV-2 Seroprevalence in a Large US population Over a Period of 12 Months
por: Karkanitsa, Maria, et al.
Publicado: (2023)

1522 Knowledge and Perception of PrEP Among Two Cohorts of Infectious Disease Providers
por: Wilson, Kerry, et al.
Publicado: (2014)

High KIAA1522 expression predicts a poor prognosis in patients with hepatocellular carcinoma
por: Xu, Yongzheng, et al.
Publicado: (2020)

The Prognostic Significance of KIAA1522 Expression in Non-Small-Cell Lung Cancer Patients
por: Özdede, Murat, et al.
Publicado: (2023)

P1522: PERIPHERAL BLOOD SMEARS DISTINGUISH INFECTIVE FEVER AFTER CAR-T THERAPY
por: He, Shaolong, et al.
Publicado: (2023)

Influenza in pregnancy
por: Memoli, Matthew J., et al.
Publicado: (2012)

Influenza Neuraminidase: A Neglected Protein and Its Potential for a Better Influenza Vaccine
por: Giurgea, Luca T., et al.
Publicado: (2020)

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016)

1522. Clinical and Molecular Epidemiology of Invasive Haemophilus influenzae Serotype a Infections in Utah Children
por: Crandall, Hillary, et al.
Publicado: (2019)

Prior infection with classical swine H1N1 influenza viruses is associated with protective immunity to the 2009 pandemic H1N1 virus
por: Kash, John C., et al.
Publicado: (2010)

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity
por: Xie, Zhi-Hui, et al.
Publicado: (2017)

KIAA1522 Promotes the Progression of Hepatocellular Carcinoma via the Activation of the Wnt/β-Catenin Signaling Pathway
por: Jiang, Shunbin, et al.
Publicado: (2020)

Coagulation Dysfunction in Patients with Liver Cirrhosis and Splenomegaly and Its Countermeasures: A Retrospective Study of 1522 Patients
por: Lv, Yunfu, et al.
Publicado: (2023)

A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy
por: Ni, Erru, et al.
Publicado: (2023)

Obese mice have increased morbidity and mortality compared to non‐obese mice during infection with the 2009 pandemic H1N1 influenza virus
por: Easterbrook, Judith D., et al.
Publicado: (2011)

1522–2022: Considerations on the First Description of the Caecal Appendix by Berengario da Carpi in its 500th Anniversary
por: Riva, Michele A., et al.
Publicado: (2022)

1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022)

Differential Effects of Influenza Virus NA, HA Head, and HA Stalk Antibodies on Peripheral Blood Leukocyte Gene Expression during Human Infection
por: Walters, Kathie-Anne, et al.
Publicado: (2019)

KIAA1522 potentiates TNFα-NFκB signaling to antagonize platinum-based chemotherapy in lung adenocarcinoma
por: Wang, Boshi, et al.
Publicado: (2020)

Development of novel DNAJB6-KIAA1522-p-mTOR three-protein prognostic prediction models for CRC
por: Jiang, Yu-Juan, et al.
Publicado: (2022)

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer
por: Sadoff, Jerald, et al.
Publicado: (2021)

The 2009 H1N1 Pandemic Influenza Virus: What Next?
por: Morens, David M., et al.
Publicado: (2010)

The PB2-E627K Mutation Attenuates Viruses Containing the 2009 H1N1 Influenza Pandemic Polymerase
por: Jagger, Brett W., et al.
Publicado: (2010)

Undiagnosed SARS-CoV-2 seropositivity during the first 6 months of the COVID-19 pandemic in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Mapping a Pandemic: SARS-CoV-2 Seropositivity in the United States
por: Kalish, Heather, et al.
Publicado: (2021)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_veb073vb7li1taqcontct0kk62